Assessing the role of venetoclax in combination with hypomethylating agents in higher risk myelodysplastic syndrome

Affiliations

Rami S. Komrokji: Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute
Avani M. Singh: Department of Hematology/Oncology, University of South Florida & Moffitt Cancer Center
Najla Al Ali: Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute
Onyee Chan: Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute
Eric Padron: Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute
Kendra Sweet: Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute
Andrew Kuykendall: Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute
Jeffrey E. Lancet: Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute
David A. Sallman: Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute

Abstract

No abstracts available.

ISSN: 2044-5385 (Online)
Publisher: Nature Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: http://www.nature.com/bcj/index.html